BAY-3018250
- Generic Name
- BAY-3018250
A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis
Phase 2
Recruiting
- Conditions
- ThrombolysisSymptomatic Proximal Deep Vein Thrombosis
- Interventions
- Drug: Placebo to BAY3018250
- First Posted Date
- 2023-11-29
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 255
- Registration Number
- NCT06149520
- Locations
- 🇮🇹
Azienda Unita Locale Socio Sanitaria 2 Marca Trevigiana | Castelfranco Veneto Hospital - Angiologia Department, Castelfranco Veneto, Italy
🇳🇱Radboud University Medical Center | Afdeling Interne Geneeskunde, Nijmegen, Netherlands
🇳🇱Isala, Zwolle, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath